SEC filing record
Primary Source · SEC.gov

TITAN MEDICAL INC

2021 vintageSecurities Exchange Act of 1934Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form 15 / Schedule TO; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalExchange Act deregistrationForm 15-15D · 2023-04-19Last filing 2023-04-19

Raised

$3M

Investors

4

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

TITAN MEDICAL INC is an entity organized in Ontario, Canada that first filed a Form D on March 28, 2012 and most recently amended it on April 19, 2023. The offering claims Securities Exchange Act of 1934. TITAN MEDICAL INC reported $3,040,800 sold from 4 investors as of the Form D filed April 19, 2023. The Form D names Bloom Burton Securities Inc., associated with Haywood Securities (USA) Inc. as the recipient of sales compensation soliciting in CA, IL, TX. The issuer's address of record is 155 University Avenue, Suite 750, Toronto, Ontario, Canada M5H 3B7.

Critical Disclosures

What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.

Reporting lapsed · Form D · last filing March 10, 2021

Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.

Timeline
Each line is a fact as filed. The history behind it, the same event across other issuers, and an alert on the next one:Open in the terminal Watch this issuer

EDGAR Filing Data

Form 15 / Schedule TO — Primary Source

View on SEC.gov
CIK Number0000840551
Entity NameTITAN MEDICAL INC
ExemptionSecurities Exchange Act of 1934
Entity Type—
Jurisdiction of OrganizationOntario, Canada
Issuer Address155 University Avenue, Suite 750, Toronto, Ontario, Canada M5H 3B7
Phone416-548-7522 X153
Industry / Fund Type—
Securities Type—
First Sale Date—
Filing DateApril 19, 2023
Accession Number0001213900-23-031013
Total Offering Amount$4,941,300
Total Amount Sold$3,040,800
Total Investors4
Minimum Investment$0 (no stated minimum)
Offering Duration—
State (Issuer Address)Ontario, Canada
Amendment Count9 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

1

latest Apr 19, 2023

Critical / warning

0 / 1

0 watch · 0 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

5

closed, lapsed, dark

Latest event Exchange act deregistration · Apr 19, 2023

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 filing event with values and deltas, latest 2023-04-19, and alerts on the next one
  • 5 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

David McNally

Executive Officer, Director · Toronto, A6

Monique L. Delorme

Executive Officer · Toronto, A6

Paul L. Cataford

Director · Toronto, A6

Anthony J. Giovinazzo

Director · Toronto, A6

Cary G. Vance

Director · Toronto, A6

Stephen G. Randall

Director · Toronto, A6

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Bloom Burton Securities Inc.

Associated broker-dealer: Haywood Securities (USA) Inc. (CRD 42072) · Vancouver, A1 · Soliciting in CA, IL, TX

Questions About TITAN MEDICAL INC

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is TITAN MEDICAL INC?

TITAN MEDICAL INC is an issuer that filed a Form D with the SEC on April 19, 2023. The filing claims Securities Exchange Act of 1934.

Is TITAN MEDICAL INC legit?

AltStreet does not rate legitimacy; it reports the public record. TITAN MEDICAL INC filed a Form D with the SEC on April 19, 2023 claiming Securities Exchange Act of 1934. A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $3,040,800 sold to 4 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is TITAN MEDICAL INC registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that TITAN MEDICAL INC claimed Securities Exchange Act of 1934 and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has TITAN MEDICAL INC raised?

TITAN MEDICAL INC reported $3,040,800 sold from 4 investors as of the Form D filed April 19, 2023.

Who is selling TITAN MEDICAL INC and how are they paid?

The Form D names Bloom Burton Securities Inc., associated with Haywood Securities (USA) Inc. as the recipient of sales compensation soliciting in CA, IL, TX.

Who is behind TITAN MEDICAL INC?

The Form D lists 6 related persons: David McNally, executive officer, director; Monique L. Delorme, executive officer; Paul L. Cataford, director; Anthony J. Giovinazzo, director; Cary G. Vance, director; Stephen G. Randall, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is TITAN MEDICAL INC located?

The issuer's address on its SEC filings is 155 University Avenue, Suite 750, Toronto, Ontario, Canada M5H 3B7. Its phone number of record is 416-548-7522 X153. It is organized under the laws of Ontario, Canada.

How long is the TITAN MEDICAL INC offering open?

An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.